
Butterfly Network BFLY
$ 4.24
-6.81%
Quarterly report 2025-Q3
added 10-31-2025
Butterfly Network Book Value 2011-2026 | BFLY
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Butterfly Network
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 169 M | 220 M | 325 M | 448 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 448 M | 169 M | 290 M |
Quarterly Book Value Butterfly Network
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 204 M | 233 M | 240 M | 182 M | 194 M | 204 M | 257 M | 278 M | 296 M | 325 M | 344 M | - | 413 M | 448 M | 451 M | 446 M | 436 M | -994 K | -994 K | -994 K | -994 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 451 M | -994 K | 247 M |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Helius Medical Technologies
HSDT
|
2.35 M | $ 2.15 | -3.15 % | $ 1.31 M | ||
|
OrthoPediatrics Corp.
KIDS
|
347 M | $ 17.57 | 2.63 % | $ 412 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | ||
|
LENSAR
LNSR
|
-12.2 M | $ 5.23 | -2.88 % | $ 62.5 M | ||
|
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | ||
|
Orthofix Medical
OFIX
|
450 M | $ 12.07 | -0.98 % | $ 478 M | ||
|
Alphatec Holdings
ATEC
|
791 M | $ 7.75 | 10.87 % | $ 1.16 B | ||
|
EDAP TMS S.A.
EDAP
|
50.1 M | $ 4.16 | 15.72 % | $ 156 M | ||
|
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | ||
|
Insulet Corporation
PODD
|
1.52 B | $ 160.4 | 6.03 % | $ 11.3 B | ||
|
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | ||
|
Sintx Technologies
SINT
|
2.93 M | $ 2.39 | -0.42 % | $ 6.63 M | ||
|
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
28 M | $ 11.68 | 1.83 % | $ 331 M | ||
|
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | ||
|
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | ||
|
Stryker Corporation
SYK
|
22.4 B | $ 294.23 | 0.65 % | $ 112 B | ||
|
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.61 | 6.93 % | $ 38 M | ||
|
LivaNova PLC
LIVN
|
1.2 B | $ 70.93 | 7.04 % | $ 3.87 B | ||
|
Delcath Systems
DCTH
|
111 M | $ 11.24 | -0.18 % | $ 403 M | ||
|
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | ||
|
Tandem Diabetes Care
TNDM
|
155 M | $ 18.47 | 2.44 % | $ 1.26 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.03 | -0.96 % | $ 17.4 M | ||
|
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
11.4 M | $ 0.87 | 2.18 % | $ 36.4 M | ||
|
Electromed
ELMD
|
43.2 M | $ 26.86 | 3.55 % | $ 227 M | ||
|
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
15.7 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
4.57 B | $ 85.07 | -4.65 % | $ 11.5 B | ||
|
CONMED Corporation
CNMD
|
1.03 B | $ 38.1 | 2.09 % | $ 1.18 B | ||
|
Inspire Medical Systems
INSP
|
781 M | $ 45.57 | -0.28 % | $ 1.34 B | ||
|
Integer Holdings Corporation
ITGR
|
1.75 B | $ 87.92 | 1.89 % | $ 3.05 B | ||
|
Varex Imaging Corporation
VREX
|
487 M | $ 11.83 | -2.79 % | $ 490 M | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 82.76 | -0.53 % | $ 48.4 B | ||
|
Tactile Systems Technology
TCMD
|
219 M | $ 26.01 | 2.81 % | $ 595 M |